A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma

Clinical trial NCT04490590 · UNKNOWN

Trial details

NCT number: NCT04490590
Sponsor: Mingzhi Zhang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

NK/T-Cell Lymphoma

Start date: 2016-10-01
Primary completion: 2020-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.